DOI: 10.1055/s-00000017

Experimental and Clinical Endocrinology & Diabetes

Issue 04 · Volume 226 · July 2014 DOI: 10.1055/s-004-26811

Review

201
Hidmark, A.; Fleming, T.; Vittas, S.; Mendler, M.; Deshpande, D.; Groener, J. B.; Müller, B. P.; Reeh, P. W.; Sauer, S. K.; Pham, M.; Muckenthaler, M. U.; Bendszus, M.; Nawroth, P. P.: A New Paradigm to Understand and Treat Diabetic Neuropathy
208
Matteucci, E.; Giampietro, O.: Epidemiology of Cardiovascular Disease in Patients with Type 1 Diabetes: European Perspective

Article

215
Ma, B.; Hu, X.; Zhao, X.; Zhang, Y.; Li, C.; Ma, Z.; Abbas, S. A.; Chen, W.; Qu, S.; Li, M.: Pharmacokinetics, Pharmacodynamics, and Cytotoxicity of Recombinant Orally-administrated long-lasting GLP-1 and its Therapeutic Effect on db/db Mice
Supplementary Material
222
Ayhan, H.; Durmaz, T.; Keleş, T.; Bayram, N. A.; Bilen, E.; Akçay, M.; Ersoy, R.; Bozkurt, E.: The Relationship between Acute Coronary Syndrome and Stress Hyperglycemia
227
Zhang, Y.; Xing, S.-Z.: Treatment of Diabetic Foot Ulcers using Mepilex Lite Dressings: A Pilot Study
231
Mackiewicz-Wysocka, M.; Araszkiewicz, A.; Schlaffke, J.; Kuczynski, S.; Micek, I.; Zozulinska-Ziolkiewicz, D.: Lower Melanin Content in the Skin of Type 1 Diabetic Patients and the Risk of Microangiopathy
236
Smith, K. J.; Rabasa-Lhoret, R.; Strychar, I.; Karelis, A. D.; Clyde, M.; Levasseur, J.; Pinaroc, C.; Pedneault, M.; Schmitz, N.: Good vs. Poor Self-rated Diabetes Control: Differences in Cardiovascular Risk and Self-care Activities
240
Kim, T. K.; Lee, J. S.; Jung, H. S.; Ha, T. K.; Kim, S. M.; Han, N.; Lee, E. J.; Kim, T. N.; Kwon, M. J.; Lee, S. H.; Kim, M. K.; Rhee, B. D.; Park, J. H.: Triiodothyronine Induces Proliferation of Pancreatic β-cells through the MAPK/ERK Pathway
246
Winkens, T.; Pachmann, K.; Freesmeyer, M.: The Influence of Radioiodine Therapy on the Number of Circulating Epithelial Cells (CEC) in Patients with Differentiated Thyroid Carcinoma – a Pilot Study
254
Xu, J.; Zhao, L.; Xiang, G.; Xu, C.: Relationship between Autoantibody to the Angiotensin II-1 Receptor and Cardiovascular Manifestations of Graves’ Disease